BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7670225)

  • 1. Assessment of two-dose vaccination schedules: availability for vaccination and catch-up strategies.
    Rouderfer V; Becker NG
    Math Biosci; 1995 Sep; 129(1):41-66. PubMed ID: 7670225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous control of measles and rubella by multidose vaccination schedules.
    Becker NG; Rouderfer V
    Math Biosci; 1996 Jan; 131(1):81-102. PubMed ID: 8589539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple dose vaccination against childhood diseases: high coverage with the first dose remains crucial for eradication.
    Paulo AC; Gomes MC; Casinhas AC; Horta A; Domingos T
    IMA J Math Appl Med Biol; 2000 Sep; 17(3):201-12. PubMed ID: 11103718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning immunity and its effects on vaccination schedules.
    Rouderfer V; Becker NG; Hethcote HW
    Math Biosci; 1994 Nov; 124(1):59-82. PubMed ID: 7827424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules.
    van den Hof S; Wallinga J; Widdowson MA; Conyn-van Spaendonck MA
    Epidemiol Infect; 2002 Feb; 128(1):47-57. PubMed ID: 11895090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccination policy.
    Williams BG; Cutts FT; Dye C
    Epidemiol Infect; 1995 Dec; 115(3):603-21. PubMed ID: 8557092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California.
    Liu F; Enanoria WT; Zipprich J; Blumberg S; Harriman K; Ackley SF; Wheaton WD; Allpress JL; Porco TC
    BMC Public Health; 2015 May; 15():447. PubMed ID: 25928152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measles vaccination].
    Floret D
    Rev Prat; 2010 Dec; 60(10):1368-70. PubMed ID: 21425529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an early two-dose measles vaccination schedule.
    Hutchins SS; Dezayas A; Le Blond K; Heath J; Bellini W; Audet S; Beeler J; Wattigney W; Markowitz L
    Am J Epidemiol; 2001 Dec; 154(11):1064-71. PubMed ID: 11724724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eradication of measles in Cuba].
    Galindo MA; Santín M; Resik S; Ribas MA; Guzmán M; Mas Lago P; Strassburg M; Hersh BS; de Quadros CA
    Rev Panam Salud Publica; 1998 Sep; 4(3):171-7. PubMed ID: 9796389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards eradication of measles virus: global progress and strategy evaluation.
    Nokes DJ; Williams JR; Butler AR
    Vet Microbiol; 1995 May; 44(2-4):333-50. PubMed ID: 8588328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.